Table 4.
Implants | Release Rate (mg/day) | Purity at 210 Days (%) | Purity at 240 Days (%) |
---|---|---|---|
TAFFB-SO 150 µm | 0.18 ± 0.03 | 94.3 | 88.8 |
TAFFB-SO 200 µm | 0.11 ± 0.04 | 91.8 | 86.7 |
TAFFB-SO 300 µm | 0.07 ± 0.02 | 96.1 | 93.2 |
TAFFB-CO 150 µm | 0.31 ± 0.06 | 80.0 | 63.5 |
TAFFB-CO 200 µm | 0.17 ± 0.07 | 81.2 | 67.9 |
TAFFB-CO 300 µm | 0.10 ± 0.02 | 90.3 | 79.0 |